Alnylam Pharmaceuticals
ALNY
#558
Rank
NZ$75.24 B
Marketcap
NZ$567.34
Share price
-0.08%
Change (1 day)
29.12%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company